Aptose Biosciences Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Aptose Biosciences Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q3 2024.
  • Aptose Biosciences Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 18.6M shares, a 186% increase year-over-year.
  • Aptose Biosciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.76M shares, a 9.82% increase from 2022.
  • Aptose Biosciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.15M shares, a 6805% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 18.6M +12.1M +186% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 16.8M +10.5M +169% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 13.1M +6.96M +113% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 6.76M +604K +9.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 6.5M +342K +5.56% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 6.23M +84K +1.37% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 6.17M -86.1M -93.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 6.15M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 6.15M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 6.15M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 92.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.